Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Biotech stocks set for a rebound in 2024, analysts say Investors warm up to sector amid stabilizing rates and an uptick in dealmaking Last Updated: Dec. 23, 2023 at 6:50 a.m. ET First Published ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

Biotech Roundup: 3 Stocks to Watch. Checking in with REGN, INCY, ... REGN) stock is finally on the rebound, after a long-term pullback from its Aug. 27, record high of $1,211.20.

While the stock’s fallen over the last five years, it’s seen a rebound in 2023, posting a 33% gain. ... This is definitely one of the biotech stocks to watch.

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Our Methodology. We used the Finviz stock screener to compile a list of 40 biotech stocks. We then selected the top 12 stocks with the highest analyst upside potential as of January 15, 2025.

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now. Provided by Dow Jones Mar 27, 2025, 5:11:00 PM. By Michael Brush .